Table 5.
Association between IGFBP3 rs2854744 and acromegaly subtype risk
| Subtype | Additive | Dominant | Recessive |
|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Microadenoma | 0.548(0.2–1.501) | 0.643(0.201–2.06) | NA |
| Macroadenoma | 0.557(0.347–0.893) | 0.524(0.295–0.932) | 0.432(0.139–1.34) |
| Combined therapy | 0.907(0.455–1.808) | 0.943(0.39–2.277) | 0.75(0.161–3.5) |
| Monotherapy | 0.512(0.316–0.828) | 0.545(0.308–0.964) | 0.21(0.047–0.939) |
NA not applicable. Significant associations are marked in bold